Alprostadil (Caverject/MUSE) Cost in Missouri 2026

What Does Alprostadil (Caverject/MUSE) Actually Cost in Missouri?

The retail cash price for alprostadil in Missouri runs approximately $600 per month in 2026, whether you are buying Caverject (intracavernosal injection) or MUSE (urethral suppository). That figure reflects the manufacturer list price set by Pfizer for Caverject and aligns with what most Missouri retail pharmacies charge without insurance or a discount program. Generic injectable alprostadil is stocked at some Missouri pharmacies and may come in slightly lower, but price variation between individual pharmacy locations can be significant. Always call ahead.

Caverject comes as a dual-chamber syringe system in 10 mcg and 20 mcg strengths. MUSE is a medicated urethral suppository available in 125 mcg, 250 mcg, 500 mcg, and 1 to 000 mcg doses. Neither is a subscription product. Both are prescribed on an on-demand basis, so the true monthly cost depends on how often the patient uses it. [A patient using four doses per month pays far less out-of-pocket than one relying on eight.] Even so, the baseline cost of the medication itself remains the central barrier for most Missouri men.

Pfizer received FDA approval for Caverject in 1995, and clinical data supporting alprostadil's efficacy appeared in the landmark Linet et al. trial published in the New England Journal of Medicine [1]. That trial enrolled 296 men with erectile dysfunction and found that intracavernosal alprostadil produced successful intercourse in 94% of injection episodes compared with 11% in the placebo group, establishing the pharmacologic foundation that still underpins prescribing today [1].

Pharmacies in St. Louis, Kansas City, Springfield, and Columbia stock Caverject and MUSE with varying regularity. Rural Missouri pharmacies may require a 3-to-5-business-day special order. Calling ahead is not optional. It is the only reliable way to confirm on-hand supply before a patient makes a trip.

GoodRx and similar discount platforms list alprostadil prices at Missouri pharmacies and can reduce the cash price by 10% to 30% at participating locations, though the final price still typically lands above $400 per month for a standard supply of Caverject. Prices shift with pharmacy contracts, so any quoted figure should be treated as an estimate rather than a guarantee [2].

Does Missouri Medicaid Cover Alprostadil?

Missouri Medicaid does not cover alprostadil for erectile dysfunction as a standalone indication. Coverage is restricted to patients whose erectile dysfunction is directly linked to a documented type 2 diabetes diagnosis. Even then, prior authorization requirements apply, and approval is not automatic.

MO HealthNet, Missouri's Medicaid program, follows a preferred drug list (PDL) that excludes most ED medications on the grounds that they treat a condition classified as lifestyle-related rather than medically necessary under standard state benefit definitions [3]. Alprostadil occupies a narrow carve-out because of its established role in diabetic neuropathy-associated ED, but the prior authorization process is demanding. Prescribers must document failed conservative treatment, a confirmed diabetes diagnosis with peripheral neuropathy or vascular involvement, and the clinical rationale for why oral PDE5 inhibitors are contraindicated or ineffective.

Patients who do qualify should expect a 2-to-4-week review timeline. Missouri Medicaid's formulary is updated quarterly, so it is worth having the prescribing clinician confirm the current PDL status before submitting a prior authorization request [3].

Missouri's dual-eligible population (patients on both Medicare and Medicaid) faces a separate pathway. Medicare Part D plans may cover alprostadil, but coverage depends entirely on the specific Part D formulary. Some plans place it on tier 3 or tier 4 with substantial cost-sharing. Others exclude it outright. Patients should request a formulary exception in writing, supported by a letter of medical necessity from their urologist or primary care physician.

The AUA (American Urological Association) guideline on erectile dysfunction notes that alprostadil "is the most efficacious pharmacological therapy for erectile dysfunction" among patients who fail or cannot tolerate oral agents [4]. That clinical weight can strengthen a prior authorization argument, particularly when paired with documented PDE5 inhibitor failure or contraindication.

Is Compounded Alprostadil Legal in Missouri?

Compounded alprostadil is legal in Missouri when prepared by a state-licensed 503A pharmacy operating under a valid prescription from a licensed prescriber. Missouri follows federal 503A compounding rules established under the Drug Quality and Security Act of 2013, which permit patient-specific compounding of alprostadil as long as it is not commercially available in the exact form prescribed [5].

This matters for cost. A 503A Missouri compounding pharmacy may prepare alprostadil injection solutions at a significantly lower price than the brand Caverject product. Some Missouri-based compounding pharmacies list compounded alprostadil at prices well below the $600 retail benchmark, though exact pricing varies by compound strength, base formulation, and quantity dispensed [5].

Combination formulas are common in compounding practice. Alprostadil is frequently combined with papaverine and phentolamine (the so-called "trimix" formulation) or with papaverine alone ("bimix"). These combinations are not FDA-approved as fixed-dose products, which is precisely why they fall within the legal scope of 503A compounding [6]. Trimix typically produces stronger erections at lower individual drug doses, which may reduce side effects like penile pain that some patients experience with alprostadil alone [6].

Missouri does not have a state-specific ban on compounded alprostadil. The Missouri Board of Pharmacy licenses and inspects 503A pharmacies, and patients should confirm that any pharmacy they use holds a current Missouri license before filling a compounded prescription [7]. Out-of-state 503A pharmacies may ship to Missouri patients, provided they hold a Missouri non-resident pharmacy permit. Confirming that permit status takes about two minutes on the Missouri Board of Pharmacy's public license lookup tool.

503B outsourcing facilities, which compound in bulk without patient-specific prescriptions, are federally regulated by the FDA and operate under stricter manufacturing standards. Alprostadil from a 503B facility is typically reserved for clinical or hospital use rather than individual patient dispensing [5].

Which Insurance Plans Cover Alprostadil in Missouri?

Coverage for alprostadil under commercial insurance in Missouri varies significantly by plan, formulary tier, and diagnosis code submitted. Most commercial plans categorize alprostadil as a specialty or non-preferred brand drug.

Employer-sponsored plans governed by ERISA (the Employee Retirement Income Security Act) may offer more flexible formulary options than ACA marketplace plans. ACA marketplace plans in Missouri are not required to cover ED medications under the essential health benefits framework, and most do not include alprostadil on their formularies without a specific rider or supplemental coverage [8].

Blue Cross Blue Shield of Missouri (Anthem), Cigna, Aetna, and UnitedHealthcare all operate plans in Missouri with varying alprostadil coverage status. The most reliable approach: call the member services number on your insurance card and ask specifically whether alprostadil (NDC 00009-3495, the Caverject 20 mcg kit) is covered under your plan's pharmacy benefit, and at what tier. Get the representative's name and a reference number for that call.

Medicare Part D coverage is plan-specific. The Centers for Medicare and Medicaid Services (CMS) do not mandate coverage of erectile dysfunction drugs, so Part D plan sponsors have discretion. Patients can use the Medicare Plan Finder tool at medicare.gov to filter by drug coverage before enrollment [9].

A documented diagnosis of organic erectile dysfunction (ICD-10 code N52.01 for erectile dysfunction due to arterial insufficiency, or N52.02 for due to corporo-venous occlusive dysfunction) rather than a vague "ED" code may improve coverage odds. Prescribers should confirm the diagnosis code submitted on the prior authorization before it goes to the insurer.

Pfizer Savings Card and Other Missouri Discount Programs

Pfizer offers a copay savings card for Caverject through its patient savings programs. Eligible commercially insured Missouri patients may pay as little as $0 to $50 per prescription fill, depending on program terms. Government-insured patients (Medicare, Medicaid, TRICARE) are not eligible for manufacturer copay cards under federal anti-kickback rules [10].

The Pfizer Patient Assistance Program (PAP) provides Caverject at no cost to uninsured or underinsured patients who meet income thresholds. Applications are submitted through NeedyMeds or directly via Pfizer's patient assistance portal. Missouri patients with household incomes at or below 400% of the federal poverty level are typically eligible, though Pfizer may adjust thresholds annually [10].

NeedyMeds, RxAssist, and the Partnership for Prescription Assistance all list Missouri-relevant assistance programs for alprostadil. These are worth checking annually because program terms change.

GoodRx Gold membership costs approximately $9.99 per month and can reduce the out-of-pocket cost at some Missouri pharmacies. Stacking a GoodRx discount with a manufacturer savings card is generally not permitted. Use one or the other.

State pharmaceutical assistance programs in Missouri (MoRx) target seniors and people with disabilities but do not specifically list alprostadil as a covered drug. Eligibility requires Missouri residency, age 65 or older or a qualifying disability, and income below a defined threshold. Applying through the Missouri Department of Health and Senior Services takes roughly 20 minutes online [11].

Can You Get Alprostadil via Telehealth in Missouri?

Telehealth prescribing of alprostadil is permitted in Missouri. State law allows licensed Missouri physicians, nurse practitioners, and physician assistants to evaluate patients and issue a prescription via synchronous audio-video telehealth visit without a prior in-person examination, provided the standard of care is met [12].

Missouri lifted many of its pre-pandemic telehealth restrictions through legislative updates that took effect in 2022, and the relevant statutes now align with standard telehealth prescribing norms. A prescriber does not need to perform a physical genital examination to prescribe alprostadil via telehealth, though a thorough history covering cardiovascular risk, medication interactions (particularly nitrates), and prior ED treatment is required [12].

The FDA labeling for alprostadil includes a contraindication for patients using nitrate medications for cardiac conditions, because the combined vasodilatory effect can cause severe hypotension [2]. Any telehealth platform prescribing alprostadil should screen for nitrate use as a mandatory step.

Missouri-licensed telehealth platforms can prescribe brand-name Caverject or MUSE. They can also generate a prescription for compounded alprostadil (or trimix) directed to a Missouri-licensed 503A pharmacy. The prescription must name a specific patient, specify the compound, dose, and quantity, and be signed by the Missouri-licensed prescriber.

HealthRX's Missouri-licensed clinicians conduct video visits for erectile dysfunction, review complete medication lists, assess cardiovascular risk using validated tools, and send prescriptions directly to the patient's preferred pharmacy. Visits typically run 20 to 30 minutes.

Clinical Background: How Alprostadil Works

Alprostadil is a synthetic analogue of prostaglandin E1 (PGE1). It binds to EP2 and EP3 receptors on smooth muscle cells in the corpus cavernosum, activating adenylyl cyclase and raising intracellular cyclic AMP (cAMP). Elevated cAMP triggers smooth muscle relaxation and arterial dilation within the erectile tissue, allowing blood to fill the corpora cavernosa and produce an erection [1].

This mechanism is entirely independent of the nitric oxide pathway that PDE5 inhibitors like sildenafil (Viagra) and tadalafil (Cialis) target. That independence is what makes alprostadil the preferred second-line therapy for men who fail oral agents. PDE5 inhibitors require functioning nitric oxide signaling, which is often impaired in men with diabetic neuropathy, radical prostatectomy, severe arteriogenic disease, or spinal cord injury. Alprostadil bypasses that pathway entirely [6].

Linet et al. (NEJM, 1996) remains the most-cited clinical anchor for alprostadil's efficacy in erectile dysfunction. The double-blind, placebo-controlled trial found that 94% of injection episodes resulted in intercourse-adequate erections in the alprostadil arm, compared with 11% in the placebo arm, across 296 enrolled men [1]. Penile pain was reported in 50% of alprostadil-treated patients but was described as mild to moderate in severity and decreased with continued use.

The AUA's erectile dysfunction guideline states: "Intracavernosal alprostadil has a high rate of success in producing erections sufficient for sexual intercourse and is recommended for men who fail or have contraindications to oral therapies" [4]. That guideline was last updated in 2018 and remains the primary U.S. standard for urologists managing ED pharmacologically.

MUSE (Medicated Urethral System for Erection) delivers alprostadil transurethrally via a small applicator inserted into the urethral meatus. Systemic absorption is lower with MUSE than with intracavernosal injection, and efficacy rates are correspondingly lower. A 1997 trial by Padma-Nathan et al. (NEJM) found that 65% of men using MUSE achieved an erection sufficient for intercourse at home, versus 19% in the placebo group, across 1,511 patients [13]. MUSE is often preferred by patients who find self-injection prohibitive.

Onset of action for Caverject is 5 to 20 minutes after injection. Duration of erection is typically 30 to 60 minutes. Patients are instructed not to inject more than once in 24 hours and no more than three times per week to reduce the risk of priapism and fibrosis [2].

Side Effects and Safety Considerations Relevant to Missouri Patients

Penile pain is the most common adverse effect of intracavernosal alprostadil, occurring in roughly 50% of users in clinical trials [1]. The pain is prostaglandin-mediated and is usually described as a dull ache rather than sharp discomfort. Trimix formulations often reduce this side effect by lowering the alprostadil component while maintaining efficacy.

Priapism (an erection lasting more than 4 hours) is a medical emergency. Patients in Missouri should be aware of the nearest emergency department capable of managing priapism with intracavernosal phenylephrine injection or surgical shunting if necessary. Barnes-Jewish Hospital (St. Louis), University of Kansas Health System (Kansas City metro), and CoxHealth (Springfield) all have urology services on call [14].

Penile fibrosis and Peyronie's disease-like plaques are associated with long-term intracavernosal injection at the same site. Rotating injection sites (left lateral, right lateral, alternating) and using the smallest effective dose reduce this risk [6].

Hypotension can occur, particularly with MUSE, due to systemic prostaglandin absorption. Missouri patients with cardiovascular disease should have their prescribing clinician review hemodynamic stability before starting alprostadil [2].

Missouri-Specific Cost Decision Framework

Selecting the lowest-cost alprostadil pathway in Missouri involves three variables: insurance status, qualifying diagnosis, and comfort with compounding pharmacies.

Step 1. Confirm insurance coverage. Call member services with the Caverject NDC and ask for formulary tier and copay. If covered at tier 2 or below, brand Caverject with a Pfizer savings card may cost $0 to $50 per fill.

Step 2. If uninsured or if insurance denies coverage, apply for Pfizer's Patient Assistance Program before paying cash. Processing takes 2 to 4 weeks. Use a 30-day GoodRx price in the interim.

Step 3. If cost remains above $200 per month after assistance programs, discuss compounded alprostadil or trimix with your prescriber. A Missouri-licensed 503A pharmacy can compound these at significantly lower cost. Confirm the pharmacy's Missouri Board of Pharmacy license before proceeding.

Step 4. If a Missouri Medicaid patient, confirm whether a type 2 diabetes diagnosis is documented. If yes, submit a prior authorization with AUA guideline citations supporting medical necessity. If denied, the appeal process is available and worth pursuing with the help of a patient advocate.

Step 5. For patients who qualify for MoRx or other state assistance programs, apply in parallel with step 2. These programs do not conflict with Pfizer's PAP for the same prescription period.

A Missouri patient with no insurance, no qualifying Medicaid diagnosis, and no access to compounding pharmacies currently faces a cash price near $600 per month. That same patient using a compounded trimix formulation from a licensed Missouri 503A pharmacy may pay under $100 per month for a comparable supply, depending on the specific pharmacy and compound ordered [5].